1. UK. Medical Research Council randomised, multicentre trial of interferon-an1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response;Allan;Lancet,1995
2. Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials;Chronic Myeloid Leukemia Trialists' Collaborative Group. (;Journal of the National Cancer Institute,1997
3. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75, 000 women;Early Breast Cancer Trialists' Collaborative Group. (;Lancet,1992
4. From efficacy to safety: a Polycythemia Vera Study Group report on hydroxyurea in patients with polycythemia vera;Fruchtman;Seminars in Hematology,1997
5. Combinations of alpha-2b interferon (INF) with hydroxyurea or cytarabine have equivalent effects on survival in early chronic phase (Abstract 4437);Giles;Blood,1999